Formulation of a Killed Whole Cell Pneumococcus Vaccine—Effect of Aluminum Adjuvants on the Antibody and IL-17 Response
This article, published in the Journal of Immune Based Therapies and Vaccines, describes preclinical research which demonstrates that a vaccine composed of killed whole cell, nonencapsulated pneumococci and formulated with aluminum hydroxide induces a strong antibody and IL-17 response.
Author(s): HogenEsch H, Dunham A, Hansen B, Anderson K, Maisonneuve JF, Hem SL
Published: 2011
Visit web page (English)
(Located at www.jibtherapies.com)
Citation: HogenEsch H, Dunham A, Hansen B, Anderson K, Maisonneuve JF, Hem SL. Formulation of a Killed Whole Cell Pneumococcus Vaccine—Effect of Aluminum Adjuvants on the Antibody and IL-17 Response. Journal of Immune Based Therapies and Vaccines. 2011;9(5).
Resource types: Peer-reviewed journal
Diseases: Pneumococcus
Topics: Disease/vaccine specific information
Regions: Global
